Cleveland Clinic announces new oncology leadership

Nathan Berger, founding director of Case Comprehensive Cancer Center, dies at 83

Nathan Berger, professor of medicine, biochemistry, oncology, and genetics; the Hanna-Payne Professor of Experimental Medicine; the director of the Center for Science, Health, and Society; and a Distinguished University Professor at Case Western Reserve University, died on June 15. He was 83.

June 21, 2024

Vol.50 No.25

By Case Comprehensive Cancer Center

In Brief

University Hospitals and Case Western Reserve research teams receive $50k in Collaborative Science Pilot Awards

Three University Hospitals and Case Western Reserve University School of Medicine research teams recently received Collaborative Science Pilot Awards.

June 30, 2023

Vol.49 No.26

Conversation with The Cancer Letter

Gary Schwartz talks about his vision for Case CCC, leaving New York, his illustrious father—and Isaac Asimov

For Gary Schwartz, leaving New York was the only difficult part of taking the top job at Case Comprehensive Cancer Center.

Cleveland Clinic opens cancer center in Abu Dhabi

His Highness Sheikh Khaled bin Mohamed bin Zayed Al Nahyan (sixth from right) and Cleveland Clinic CEO and President Tom Mihaljevic (seventh from right), with dignitaries, clinical staff at the opening of the Fatima bint Mubarak Center at Cleveland Clinic Abu Dhabi.Source: Cleveland ClinicCleveland Clinic has opened a cancer facility named the Fatima bint Mubarak Center, at Cleveland Clinic Abu Dhabi.

March 10, 2023

Vol.49 No.10

In Brief

Gary Schwartz named director at Case CCC

Gary Schwartz, chief of the Hematology & Oncology Division at Columbia University Irving Medical Center and deputy director of its Herbert Irving Comprehensive Cancer Center, was named director of Case Comprehensive Cancer Center.

January 13, 2023

Vol.49 No.02

Clinical Roundup

Multicenter study reveals worse outcomes in understudied breast cancer

A multicenter analysis of patients with invasive lobular carcinoma—the second most common histological subtype of invasive breast cancer in the U.S.—showed that, despite its prevalence, ILC is detected later and has worse outcomes than the predominant subtype of invasive breast cancer, known as invasive ductal carcinoma, or no special type.

December 02, 2022

Vol.48 No.43

Cleveland Clinic announces new oncology leadership

YOU MAY BE INTERESTED IN

Nathan Berger, founding director of Case Comprehensive Cancer Center, dies at 83

University Hospitals and Case Western Reserve research teams receive $50k in Collaborative Science Pilot Awards

Gary Schwartz talks about his vision for Case CCC, leaving New York, his illustrious father—and Isaac Asimov

Cleveland Clinic opens cancer center in Abu Dhabi

Gary Schwartz named director at Case CCC

Multicenter study reveals worse outcomes in understudied breast cancer

Renew today!

Subscriber content

Never miss an issue!

Login